Researchers look to the future for defeating blindness

Aug 04, 2010
A retina with the degenerative vision disease, retinitis pigmentosa (right) is compared to a healthy retina. Credit: Friedrich Miescher Institute for Biomedical Research

Neurobiologists funded by the Office of Naval Research (ONR) have discovered a potential cure for degenerative vision diseases leading to terminal blindness.

The solution, however, may be rooted in an unconventional therapeutic approach.

Scientists at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, are manipulating the proteins that cause blindness in mice. The scientists have successfully restored vision in the light-sensing cells of the retina.

Dr. Thomas McKenna, program officer for ONR's Neural Computation Program, said this research has significant future implications.

"In the course of their study, these researchers discovered an approach to restore vision in blind mice with congenital macular degeneration," McKenna said. "This technology shows great promise for the partial restoration of vision for blind patients."

This initiative, supported by ONR Global's Naval International Cooperative Opportunities in Science and Technology Program (NICOP), studies retinitis pigmentosa, the incurable genetic eye disease, which causes more than 2 million worldwide cases of tunnel vision and night blindness. If left untreated, the disease can lead to complete as the color-sensing cells in the retina slowly degenerate.

Dr. Clay Stewart, technical director, ONR Global, explained the importance of the NICOP program for providing a platform for innovative international basic research that could ultimately have a profound impact on naval activities.

"The NICOP grants are of a seedling nature and are aimed at maturing foreign science and technology projects to the point that they can be picked up by ONR or other [Naval Research Enterprise] organizations," Stewart said. "In the case at hand, this world-class cognitive research team has developed science that has the potential of being useful in restoration of in subjects with impaired , such as Sailors or Marines who have sustained head injuries in combat."

McKenna, a recipient of the 2009 Delores M. Etter Top Scientists and Engineers of the Year award, said additional studies are needed before making the treatment available to visually challenged populations. Next, the team plans to explore the duration of therapeutic effects and whether the gene therapy could have applications for other eye diseases.

Explore further: Skin patch could help heal, prevent diabetic ulcers, study finds

Provided by Office of Naval Research

5 /5 (3 votes)
add to favorites email to friend print save as pdf

Related Stories

Microbial protein restores vision in blind animals

Jul 14, 2010

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) restore vision in retinitis pigmentosa using an archaebacterial protein. Introducing halorhodopsin into the remaining ...

Making the blind see: Gene therapy restores vision in mice

Mar 31, 2010

Take a look at this: Scientists from Buffalo, Cleveland, and Oklahoma City made a huge step toward making the blind see, and they did it by using a form of gene therapy that does not involve the use of modified viruses. In ...

Sight recovery in mice

Jun 24, 2010

Swiss researchers from the Friedrich Miescher Institute, in collaboration with Inserm researchers from CNRS and UPMC in the Institut de la Vision, have restored sight to mice afflicted with retinitis pigmentosa. The results ...

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Bookbinder
not rated yet Aug 04, 2010
This alleged article tells me nothing about the socalled breakthrough or therapeutic process.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.